Monosialoganglioside GM1, Solution for Injection (Sodium Monosialotetrahexosylganglioside (GM1) Injection) 单唾液酸四己糖神经节苷脂钠注射液

Drug Description

Ganglioside GM1, solution for injection, is a medication widely used in clinical practice to treat a range of neurological conditions in both children and adults. The main active ingredient of the drug is ganglioside GM1, which is an important component of cell membranes and plays a key role in maintaining and restoring nerve cells.

Key Properties of Ganglioside GM1

Neuroprotective Effect

• Ganglioside GM1 protects nerve cells from damage and promotes the restoration of their structure and function.
• The drug improves neuroplasticity by stimulating the growth and repair of damaged nerve fibers.

Improved Neurotransmission

• Ganglioside GM1 helps improve the transmission of nerve impulses, which is essential for the normal functioning of the nervous system.

Stimulation of Nerve Cell Regeneration

• The drug activates the regeneration of neurons, which is especially important in treating injuries to the central and peripheral nervous system.

Indications

Cerebral Palsy (CP)

• The drug is used in the comprehensive therapy of children with cerebral palsy to improve cognitive and motor functions. Ganglioside GM1 promotes the restoration of nerve cells, improving movement coordination and overall neuroplasticity.

Developmental Delay

• "Sodium ganglioside GM1" can be used to treat children with psychomotor and speech developmental delay. The drug helps stimulate the development of the nervous system, improving cognitive functions and supporting normal brain development.

Intellectual Disability

• The drug may be used to improve cognitive abilities in children with intellectual disability, supporting their learning and development by sustaining nervous system function.

Traumatic Brain Injury

• "Sodium ganglioside GM1" is used to restore nerve function after traumatic brain injury. The drug helps reduce the consequences of injury, improving cognitive and motor functions.

Stroke

• The drug is used in post-stroke rehabilitation, promoting the restoration of damaged nerve cells and the improvement of motor functions.

Neurodegenerative Diseases

• The drug may be used in the therapy of central nervous system diseases, such as Alzheimer's disease and Parkinson's disease, owing to its ability to support and restore nerve cells.

Optic Nerve Atrophy

• "Sodium ganglioside GM1" is used to treat optic nerve atrophy, improving the condition of nerve fibers and supporting visual function.

Brain Injuries

• The drug is used to treat the consequences of brain injuries, helping to restore damaged nerve tissue and improve overall cognitive function.

Dosage and Administration

• Injections: The drug is administered intramuscularly or intravenously, depending on the clinical situation and the physician's recommendations.
• Dosage: Prescribed individually, taking into account the patient's age, diagnosis, and severity of the condition.

Side Effects

• In rare cases, local reactions at the injection site, such as redness or itching, may occur.
• Allergic reactions are possible, including urticaria or anaphylaxis.

Contraindications

• Hypersensitivity to the components of the drug.
• Use with caution in patients with a history of allergic diseases.

Storage

• Store in a dry, cool place protected from light, at a temperature not exceeding +8°C.

Conclusion

Ganglioside, solution for injection, is an important agent in the comprehensive therapy of neurological conditions in children and adults. The drug helps treat children with cerebral palsy, developmental delay, and intellectual disability, and is also used in the rehabilitation of adults after traumatic brain injury and stroke, as well as in neurodegenerative diseases, promoting the restoration and support of nervous system function.